By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Heron Therapeutics, Inc. (Formerly known as A.P. Pharma, Inc.) 

123 Saginaw Drive

Redwood City  California  94063  U.S.A.
Phone: 650-366-2626 Fax: 650-365-6490




Company News
Heron (HRTX) Reports Financial Results For The Three Months Ended March 31, 2017 And Recent Corporate Progress 5/10/2017 8:17:42 AM
Heron (HRTX) Appoints Robert E. Hoffman As Chief Financial Officer and Senior Vice President, Finance 4/25/2017 7:15:24 AM
Heron (HRTX) Announces Inclusion Of SUSTOL (Granisetron) Extended-Release Injection In NCCN Antiemesis Guidelines 2/24/2017 6:50:44 AM
Heron (HRTX) Announces Fourth Quarter And Full Year 2016 Financial Results And Recent Corporate Progress 2/24/2017 6:40:42 AM
Heron (HRTX) Announces Underwriters’ Exercise In Full Of Option To Purchase Additional Shares 1/31/2017 10:14:56 AM
Heron (HRTX) Release: Biotech Announces Pricing Of Underwritten Public Offering Of Common Stock 1/19/2017 7:22:52 AM
Heron (HRTX) Release: Biotech Announces Proposed Public Offering Of Common Stock 1/19/2017 7:20:44 AM
Heron (HRTX) Establishes Synergy Of Bupivacaine And Meloxicam With HTX-011 For Prevention Of Post-Operative Pain In Phase 2 Clinical Studies 1/5/2017 11:21:39 AM
Heron (HRTX) Announces Positive Topline Results From Phase 2 Clinical Trial Of HTX-011 In Abdominoplasty 1/5/2017 11:19:21 AM
Heron (HRTX) Release: Biotech Announces Submission Of CINVANTI NDA For The Prevention Of Chemotherapy-Induced Nausea And Vomiting (CINV) 12/15/2016 1:30:56 PM